GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TRACON Pharmaceuticals Inc (STU:T051) » Definitions » Credit Losses Provision

TRACON Pharmaceuticals (STU:T051) Credit Losses Provision


View and export this data going back to 2015. Start your Free Trial

What is TRACON Pharmaceuticals Credit Losses Provision?

Credit Losses Provision only applies to banks.


TRACON Pharmaceuticals (STU:T051) Business Description

Traded in Other Exchanges
Address
4350 La Jolla Village Drive, Suite 800, San Diego, CA, USA, 92122
TRACON Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing its cost efficient, contract research organization (CRO) independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the United States. The company's drug candidate includes Envafolimab, TRC102, TRC253, and Bispecific Antibodies.